bluebird bio Announces May Investor Events
May 03 2021 - 8:00AM
Business Wire
bluebird bio, Inc. (NASDAQ: BLUE) today announced that members
of the management team will participate in the following upcoming
investor conferences:
- BofA Securities 2021 Health Care Conference, Thursday, May 13,
at 9:30 am ET
- 2021 RBC Capital Markets Global Healthcare Conference,
Wednesday, May 19, at 1:55 pm ET
To access the live webcast of bluebird bio’s presentations,
please visit the “Events & Presentations” page within the
Investors & Media section of the bluebird bio website at
http://investor.bluebirdbio.com. A replay of the webcasts will be
available on the bluebird bio website for 90 days following the
event.
About bluebird bio, Inc.
bluebird bio is pioneering gene therapy with purpose. From our
Cambridge, Mass., headquarters, we’re developing gene and cell
therapies for severe genetic diseases and cancer, with the goal
that people facing potentially fatal conditions with limited
treatment options can live their lives fully. Beyond our labs,
we’re working to positively disrupt the healthcare system to create
access, transparency and education so that gene therapy can become
available to all those who can benefit.
bluebird bio is a human company powered by human stories. We’re
putting our care and expertise to work across a spectrum of
disorders: cerebral adrenoleukodystrophy, sickle cell disease,
β-thalassemia and multiple myeloma, using gene and cell therapy
technologies including gene addition, and (megaTAL-enabled) gene
editing.
bluebird bio has additional nests in Seattle, Wash.; Durham,
N.C.; and Zug, Switzerland. For more information, visit
bluebirdbio.com.
Follow bluebird bio on social media: @bluebirdbio, LinkedIn,
Instagram and YouTube.
bluebird bio is a trademark of bluebird bio, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210503005391/en/
Investors & Media
Investors:
Ingrid Goldberg, 857-217-0490 igoldberg@bluebirdbio.com
Elizabeth Pingpank, 617-914-8736 epingpank@bluebirdbio.com
Media:
Jenn Snyder, 617-448-0281 jsnyder@bluebirdbio.com
Catherine Falcetti, 617-583-3411 cfalcetti@bluebirdbio.com
bluebird bio (NASDAQ:BLUE)
Historical Stock Chart
From Aug 2024 to Sep 2024
bluebird bio (NASDAQ:BLUE)
Historical Stock Chart
From Sep 2023 to Sep 2024